Lunit
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Software · South Korea · 201-500 Employees
View Company Info for Free
Overview
Headquarters
27 Teheran-ro 2-gil 15 Fl, Gangnam-gu, S...Website
www.lunit.ioRevenue
$58.8 MillionStock Symbol
328130.KQIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
2
2
1
1
2
About Lunit
With AI, Lunit aims to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide. We develop AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients.Explore more
Lunit Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lunit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Lunit has new funding data
Website visits: Recent activity has been detected on your website
Lunit, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Lunit has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Lunit
Click to see if Lunit had a recent Job posting/layoffs
Check out if Lunit is spiking on competitors!
Product Launch: Get notified when Lunit launches new products
Earning: See what the market has to say on Lunit recently announced quarterly report
Recommended Actions
Find VP level buyers at Lunit
Find 2 more new buyers
Company Profile Activity
Activity Insights
Lunit is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Lunit is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Lunit.
Lunit financials insights
Gather financial insights about Lunit, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$3.5M
2018
Series B
$15M
2021
Series C
$78M
Other Financing Round
$61M
2023
Other Financing Round
$150M
Lunit Tech Stack
A closer look at the technologies used by Lunit
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Lunit News & Media
Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026
Three studies explore the relationship between tumor microenvironment, genomic alterations, and treatment response in non-small cell lung cancer using AI-based analysis SEOUL, South Korea, Sept. 8, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics...Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology research through AI-powered HER2/IHC biomarker quantification and spatial tumor microenvironment analysis. SEOUL, South Korea, May 21, 2026 /PRNewswire/ -- Lunit, a leading provider of AI for...Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making. SEOUL,...Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making. SEOUL, South Korea, April 18, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, presented six studies at the American Association for Cancer Research (AAC
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lunit
Sign Up For FreeTo access detailed company insights
With AI, Lunit aims to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide. We develop AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients.... Read More
